Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03297229
Other study ID # AR-T1087-P0001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 4, 2017
Est. completion date March 1, 2018

Study information

Verified date September 2017
Source Institute for Clinical Effectiveness and Health Policy
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cardiovascular diseases are increasing throughout the developing world and are the cause of almost 16.7 million deaths each year, of which 80% occur in low and middle-income countries. As more than three fourth of the global burden of cardiometabolic diseases are related to risk factors connected with lifestyles or behaviors, such as smoking, unhealthy eating, low physical activity, and harmful consumption of alcohol. This burden could be dramatically reduced by changing individual behaviors. This study is focused on interventions that are aimed to improve the adherence to treatment in cardiovascular disease (hypertension), based on a Behavioral Economics approach. Most of public policies targeted to tackle Noncommunicable diseases utilize a rational economic model of behavior. Behavioral economics, by using insights from cognitive psychology and other social sciences, has drawn a lot of attention for its potential to increase healthy behaviors. Interventions informed by Behavioral economics principles seek to rearrange the social or physical environment in such a way to 'nudge' people towards healthier choices and behaviors. This is an individual controlled randomized trial which will be conducted to assess whether the implementation of two strategies, blood pressure self-monitoring plus signing a "contract of commitment", and peer mentoring are effective to reduce blood pressure values over a period of 3 months, compared to usual care. This randomized trial will enroll 430 patients from 10 public primary care clinics in Argentina.


Recruitment information / eligibility

Status Completed
Enrollment 442
Est. completion date March 1, 2018
Est. primary completion date February 1, 2018
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - Adults (21 years and older) who only have public health coverage, and have high blood pressure (SBP =140 mmHg and / or DBP =90 mmHg) Exclusion Criteria: - Pregnant women, bed-bound, and patients who cannot give informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Peer mentoring
Peers will be assigned to participants according to common socio-demographic characteristics. Each peer will be assigned up to 5 participants.
Self-monitoring
Along with providing patients with a BP monitor, a "commitment contract" will be signed, in which participants commit themselves to measure their blood pressure at home at least once a week during the 3 months of the intervention. Each participant will be given a form to weekly recording their blood pressure values.

Locations

Country Name City State
Argentina Centro de Atención Primaria de la Salud Dr. Balbastro Corrientes
Argentina Centro de Atención Primaria de la Salud N°15 Illia Corrientes
Argentina CAPS 1 Simeon Payba Paso de los Libres Corrientes
Argentina CAPS 10 Plurianual Paso de los Libres Corrientes
Argentina Centro Asistencial Modelo Don Bosco Quilmes Buenos Aires.
Argentina Policlínico Julio Méndez Quilmes Buenos Aires.
Argentina Centro de Salud nº 60 - El Mirador Salta
Argentina Centro de Salud Santa Ana Salta
Argentina UAP Illia Vicente López Buenos Aires
Argentina UAP Sargento Cabral Vicente López Buenos Aires

Sponsors (2)

Lead Sponsor Collaborator
Institute for Clinical Effectiveness and Health Policy Inter-American Development Bank

Country where clinical trial is conducted

Argentina, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure Net change in blood pressure levels from baseline to the end of follow-up in in each group. 3 months
Secondary Controlled hypertension Proportion of patients with controlled hypertension (Systolic blood pressure <140 mm Hg and diastolic blood pressure <90 mm Hg) 3 months
Secondary Adherence to antihypertensive medication Proportion of patients who had adhered to antihypertensive medication according to the Morisky Green Scale. 3 months
Secondary Intensification of antihypertensive medication Proportion of patients who increased the number of antihypertensive medications or increase the dose of their antihypertensive medication. 3 months
Secondary Visits to the clinic Number of visits to the clinic over the 3 month period of follow-up. 3 months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A